首页> 外文期刊>International Journal of Animal and Veterinary Advances >Efficacy of Ceftobiprole in Treating of Osteomyelitis Due to Methicillin Resistant Staphylococcus aureusin Rabbits
【24h】

Efficacy of Ceftobiprole in Treating of Osteomyelitis Due to Methicillin Resistant Staphylococcus aureusin Rabbits

机译:头孢比普林治疗耐甲氧西林金黄色葡萄球菌引起的骨髓炎的疗效

获取原文
       

摘要

The present study was carried out to investigate antibacterial activity of ceftobiprole and vancomycin in-vitro and in-vivo after inducing osteomyelitis in rabbit by administration of Methicillin Resistant Staphylococcus Aureus (MRSA). Part I, evaluation is done in-vitro by using hot plate method for appearance zone of inhibition and Minimum Inhibitory Concentration (MIC) against (MRSA). Antibacterial susceptibility test showed that the ceftobiprole was more effective than vancomycin. Part II, inducing osteomyelitis (40 mg/kg B.W) compared with treated with vancomycin at a dose of (30 mg/kg B.W) subcutaneously for 28 days. Ceftobiprole succeeded to treat osteomyelitis by absence methicillin resistant staphylococcus aureus in the infected rabbits and prevented infection compared with vancomycin and radiographic pictures explained normal bone anatomy and all features of osteomyelitis disappeared These results indicate that ceftobiprole provided effective parenteral treatment of osteomyelit is in this rabbit model.
机译:本研究旨在研究耐甲氧西林金黄色葡萄球菌(MRSA)诱导兔骨髓炎后头孢比普利和万古霉素的体外和体内抗菌活性。第一部分,通过使用热板法对抑制的外观区域和针对(MRSA)的最小抑制浓度(MIC)进行体外评估。抗菌药敏试验表明头孢比普林比万古霉素更有效。第二部分与皮下注射万古霉素(30 mg / kg B.W)皮下注射28天相比,诱发骨髓炎(40 mg / kg B.W)。与万古霉素相比,头孢比普利通过不存在耐甲氧西林的金黄色葡萄球菌成功地治疗了骨髓炎,并且与万古霉素相比可以预防感染,并且放射照片解释了正常的骨骼解剖结构,并且骨髓炎的所有特征都消失了。这些结果表明,头孢比普利提供了有效的肠胃外胃肠外治疗骨髓炎的方法。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号